Latest Distributions News

Botanix Pharmaceuticals’ ECCLOCK® gel, a treatment for excessive sweating, has secured regulatory approval in South Korea, paving the way for a commercial launch in early 2026.

Auric Mining has completed the final toll milling campaign at Jeffreys Find, securing a substantial profit share and setting the stage for expanded operations at its Munda Gold Mine.

Evolution Energy Minerals has announced that its recent entitlement offer is now fully underwritten by Mahe Capital, with key directors participating as sub-underwriters, removing previous minimum subscription conditions.

BlackRock Investment Management (Australia) Limited has announced an estimated cash distribution of 31.1262 cents per unit for its iShares Core Cash ETF (ASX – BILL), with key dates set for early to mid-September 2025.

Wesfarmers Limited has updated its dividend details, confirming a fully franked ordinary dividend of AUD 1.11 per share payable on 7 October 2025, with shareholders able to receive payments in AUD, NZD, or GBP.

Duxton Farms has reached a key milestone in its merger with four agricultural businesses, securing ASIC registration of scheme books and scheduling crucial shareholder meetings for October.

Australian United Investment Company Limited has updated its dividend announcement to include the Dividend Reinvestment Plan issue price, confirming a fully franked total dividend of AUD 0.28 per share for the period ending June 2025.

The Russell Investments Australian Responsible Investment ETF (RARI) posted a solid 18.77% total return for the year ending June 2025, slightly trailing its benchmark index. This update highlights the fund's steady performance amid evolving market conditions.

Vicinity Centres has updated its dividend distribution details for the six months ending June 2025, including the Dividend Reinvestment Plan price and the NZD equivalent payout for New Zealand investors.

Centuria Industrial REIT has successfully settled a A$325 million exchangeable notes offering due 2030, simultaneously repurchasing nearly A$300 million of its higher-cost notes maturing in 2028. This refinancing move aims to extend debt maturity and reduce interest expenses.

Control Bionics Limited has announced a 1-for-5 non-renounceable rights issue to raise up to $2.06 million, aiming to fund the commercial expansion of its NeuroStrip® device and operational growth. The offer is partially underwritten and open to eligible shareholders in Australia and New Zealand.

WAM Income Maximiser Limited has declared a fully franked dividend for September, reflecting robust portfolio growth since its April 2025 launch. The investment portfolio has outperformed benchmarks, positioning the company well for its income return targets.